Skip to main content

Needle-Free Buccal Peptide Delivery How It Works and Where NeoPep Fits

Page 1

Needle-Free Buccal Peptide Delivery: How It Works and Where NeoPep Fits

NeoPep Research | neopeplife.com


How buccal delivery works 1

2

3

4

5

Place

Release

Reach

Cross

Enter

Patch sits against the inner cheek

Formulation controls how the peptide becomes available

Peptide stays near the buccal mucosa

Peptide moves through the mucosal tissue

Peptide reaches systemic circulation

Unlike a swallowed peptide, it does not have to pass the stomach and intestines first, so initial GI exposure is reduced.


Buccal vs oral vs injectable Factor

Buccal

Swallowed oral

Injectable

Route

Through the cheek mucosa

Through the GI tract

Through injection

GI exposure

Reduced initial exposure

Direct exposure

Generally avoided

First-pass metabolism

Can reduce hepatic exposure

Can occur after absorption

Generally bypassed

Needle required

No

No

Yes

Bioavailability still depends on the peptide: size, structure, stability and permeability all matter.


5 benefits of buccal delivery 1

Needle-free

2

Reduced GI exposure

3

Less first-pass exposure

4

Controlled release

5

Formulation flexibility

No injection required

Formulation decides the outcome

Less contact with acid and enzymes

Can reduce the hepatic first-pass effect

Hydrogels and polymers shape release

Multilayer designs suit each peptide

Stability, controlled release and mucosal contact must work together for the peptide to cross the tissue.


The NeoPep patch platform TD-IntelGel™

Muco-SmartSeal®

Hydrogel-based tri-layer patch system

Keeps the patch in contact with the cheek

Stabilized peptide matrix Controlled trans-diffusion through the buccal membrane Cold manufacturing to preserve structure and potency

Maintains patch position Helps limit peptide loss into saliva Supports buccal absorption at the delivery site


What the 81% result means 100

81% TD-IntelGel buccal patch in PermeaPad testing. NeoPep Innovations internal testing.

80

81.0

60

40 32.0 20

0

1.0

2.0

2.0

1.0

3.0

4.0

In-vitro result only. It is not clinical bioavailability, which needs pharmacokinetic data from living subjects.


Thank You Building a peptide product? Talk to our team about the TD-IntelGel buccal delivery platform.

neopeplife.com sales@neopeplife.com


Turn static files into dynamic content formats.

Create a flipbook